Comparison of cilostazol and clopidogrel after successful coronary stenting.
Lee, SW; Park, SW; Hong, MK; Lee, CW; Kim, YH; Park, JH; Kang, SJ; Han, KH; Kim, JJ; Park, SJ
The American journal of cardiology, 95(7):859-862, 2005
The American journal of cardiology
This study compared the safety and efficacy of cilostazol and clopidogrel after coronary stenting. Patients (n = 689) who underwent successful stenting were randomly assigned to receive cilostazol (group 1, n = 344, 612 lesions) or clopidogrel (group 2, n = 345, 628 lesions). The incidence of subacute stent thrombosis or major adverse cardiac events, including death, myocardial infarction, and target lesion revascularization within 30 days (2.6% in group 1 vs 2.0% in group 2, p = 0.61) and side effects that required cessation of study drug (0.6% each) did not differ statistically between groups. These results indicate that cilostazol is as safe and effective as clopidogrel in preventing thrombotic complications after stenting.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
Total Visit :2,784,019
Total Download :1,135,425
Today View :1,253
Ajou University Medical Information & Media Center 164 Worldcup-ro Yeongtong-gu Suwon 16499 Korea / TEL : 031-219-5312 / FAX : 031-219-5314 Copyright (c) Ajou University Medical Information & Media Center All Rights Reserved. AJOU Open Repository는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.